2023-10-09T09:59:31-05:00 2022-12-31 910189318 MOSS ADAMS LLP 6565 AMERICAS PARKWAY NE STE 600 ALBUQUERQUE NM 87110 990 2022-01-01 204404637 KENDALL & TAYLOR ATKINSON FOUNDATION KEND 3033491309 PO BOX 3514 LITTLETON CO 801613514 JEANNE ATKINSON TREASURER 3033491309 2023-10-05 1 JEANNE ATKINSON 999009999 0 PAMELA ALEXANDERSON P01218925 5058787200 2023-10-05 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z JEANNE ATKINSON 6192 E LONG CIR SO CENTENNIAL CO 80112 250597 0 X WWW.KATAFOUNDATION.ORG X 2006 CO TO RAISE MONEY FOR CHARITABLE ALLOCATION. 8 8 0 35 0 0 229515 162262 0 0 0 0 -33516 16554 195999 178816 137000 190000 0 0 0 0 0 0 0 6583 6451 143583 196451 52416 -17635 80595 62960 0 0 80595 62960 X TO RAISE MONEY FOR CHARITABLE ALLOCATION. 0 0 190000 190000 **ALLOCATIONS WERE MADE TO THE FANCONI ANEMIA RESEARCH FUND TO SUPPORT MEDICAL, SCIENTIFIC AND TREATMENT RESEARCH OF FANCONI ANEMIA AND ITS RELATED CANCERS.*$100,000 WAS ALLOCATED TO FUND RESEARCH ENTITLED DEVELOPMENT AND CHARACTERIZATION OF FA HEAD & NECK CANCER MODELS. THE RESEARCH IS BEING CONDUCTED BY JENNIFER GRANDIS, MD, UNIVERSITY OF CALIFORNIA SAN FRANCISCO. LABORATORY MODELS OF FA HEAD AND NECK CANCER ARE LACKING AND REPRESENT A MAJOR BARRIER TO IDENTIFYING MORE EFFECTIVE TREATMENTS. RESEARCHERS HAVE HELPED PIONEER THE CREATION OF PATIENT-DERIVED XENOGRAFTS(PDX) FROM HEAD AND NECK CANCERS AND HAVE DEVELOPED THE FIRST PDX FROM A HEAD AND NECK CANCER IN A FA PATIENT. PRELIMINARY STUDIES USING THIS PDX DEMONSTRATE SENSITIVITY TO DRUGS THAT TARGET GENES THAT ARE AMPLIFIED IN THE PATIENT'S TUMOR. THIS RESEARCH WILL BUILD ON THIS EXCITING WORK TO DEVELOP A COLLECTION OF WELL-CHARACTERIZED PDXS FROM HEAD AND NECK CANCERS IN FA PATIENTS TO GUIDE PRECISION MEDICINE APPROACHES FOR THIS MALIGNANCY THAT IS LETHAL TO FA PATIENTS. **ALLOCATIONS WERE MADE TO THE UNIVERSITY OF COLORADO FOUNDATION. *$15,500 WAS ALLOCATED TO THE UNIVERSITY OF COLORADO FOUNDATION FOR THE KENNETH R ATKINSON MD ENDOWED MEMORIAL SCHOLARSHIP.DISTRIBUTION OF FUNDS WAS MADE TO AN ENDOWED SCHOLARSHIP TO BE AWARDED ANNUALLY TO A STUDENT ENROLLED IN THE SCHOOL OF MEDICINE AT THE UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS. SCHOLARSHIP IS NEED BASED WITH PREFERENCE GIVEN TO 4TH YEAR MEDICAL STUDENTS WHO PLAN ON GOING INTO PRIMARY CARE MEDICINE. PREFERENCE WILL ALSO BE GIVEN TO STUDENTS INTENDING TO PRACTICE PRIMARY CARE IN THE STATE OF COLORADO.**ALLOCATIONS WERE MADE TO CAMP BARNABAS IN SOUTHWEST MISSOURI TO ENHANCE THE CAMP EXPERIENCE FOR KIDS WITH SPECIAL NEEDS AND TO MEET THE MEDICAL NEEDS OF ALL CAMPERS.*$2,500 WAS ALLOCATED FOR AN EKG MACHINE*$10,00 WAS ALLOCATED FOR UPDATED KITCHEN EQUIPMENT$2,500 WAS ALLOCATED FOR CAMPER SCHOLARSHIPSCAMP BARNABAS PROVIDES A UNIQUE CAMP EXPERIENCE FOR INDIVIDUALS WITH SPECIAL NEEDS. THE CAMP WANTS ITS CAMPERS TO HAVE A SUMMER JUST LIKE EVERYONE ELSE BECAUSE, FOR MOST OF THE YEAR, ITS CAMPERS ARE ON THE OUTSIDE. SPECIAL NEEDS INDIVIDUALS SPEND THEIR YEAR ADAPTING AND MAKING MODIFICATIONS TO THEIR LIVES AND ROUTINES IN ORDER TO FUNCTION IN THE WORLD AROUND THEM. CAMP BARNABAS WANTS CAMPERS TO FEEL LIMITLESS AND TO CREATE A PLACE WHERE THEY CAN FEEL THE FREEDOM TO BE WHO THEY WERE DESIGNED TO BE. THE CAMP INCLUDES AN ONSITE MEDICAL FACILITY WITH NURSES AND DOCTORS TO ACCOMMODATE THE MEDICAL NEEDS OF ITS CAMPERS. 190000 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 8 8 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 CO X JEANNE ATKINSON 3033491309 6192 E LONG CIR SO CENTENNIAL CO 80112 X STEVE RICE PRESIDENT 4.00 X X 0 0 0 JEANNE ATKINSON TREASURER 4.00 X X 0 0 0 SHELLY BEARD SECRETARY 4.00 X X 0 0 0 RICHARD DICK BEARD BOARD MEMBER 4.00 X 0 0 0 ANGIE RICE BOARD MEMBER 4.00 X 0 0 0 ADAM SANDS BOARD MEMBER 4.00 X 0 0 0 LINDA JOY WURTZBACHER BOARD MEMBER 4.00 X 0 0 0 MATT WURTZBACHER BOARD MEMBER 4.00 X 0 0 0 0 0 0 0 0 0 0 0 111415 50847 162262 88335 111415 71781 16554 16554 178816 0 0 16554 190000 190000 175 175 536 536 283 283 1360 1360 MISCELLANEOUS OPERATION 4097 4097 196451 190000 6451 0 80595 62960 80595 62960 0 0 X 80595 62960 80595 62960 80595 62960 -17635 0 X 0 0 0 X 338890 329121 190428 229515 162262 1250216 338890 329121 190428 229515 162262 1250216 349424 900792 75 99 193 0 367 116 116 1250699 215918 0.72020 0.77380 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED BARN DINNER 108810 20475 88335 15311 15203 5250 33319 HOPE FLOATS 90940 90940 1048 1650 199750 111415 88335 1048 15311 15203 5250 34969 71781 16554 1 FANCONI ANEMIA RESEARCH FUND 1801 WILLIAMETTE SUITE 200 EUGENE OR 97401 930995453 501(C)(3) 140000 0 TO SUPPORT SCIENTIFIC, MEDICAL, AND TREATMENT RESEARCH OF FANCONI ANEMIA AND ITS RELATED CANCERS AND TO PROVIDE EDUCATION AND SUPPORT SERVICES TO AFFECTED FAMILIES. CHILDREN'S HOSPITAL COLORADO FOUNDATION 13123 E 16TH AVENUE BOX 045 AURORA CO 80045 840813462 501(C)(3) 25000 0 GENERAL PURPOSE UNIVERSITY OF COLORADO FOUNDATION 1800 N GRANT ST STE 725 DENVER CO 80203 846049811 501(C)(3) 25000 0 KENNETH R ATKINSON MD ENDOWED MEMORIAL SCHOLARSHIP 3 0 PART IV LINE 2 THE BOARD ANNUALLY ASKS FOR AND RECEIVES AN UPDATE ON THE PROGRESS OF THE RESEARCH THAT WAS FUNDED FOR ALL YEARS. IN THE CASE OF NON-RESEARCH FUNDING, THE MONITORING VARIES DEPENDING ON THE PROJECT FUNDED. FORM 990, PART VI, SECTION A, LINE 2 STEVE RICE, BOARD PRESIDENT, AND ANGIE RICE, BOARD MEMBER, FAMILY RELATIONSHIP SHELLY BEARD, BOARD SECRETARY, AND RICHARD BEARD, BOARD MEMBER, FAMILY RELATIONSHIP LINDA JOY WURTZBACHER AND MATT WURTZBACHER, BOARD MEMBERS, FAMILY RELATIONSHIP FORM 990, PART VI, SECTION B, LINE 11B COPIES OF THE FORM 990 ARE PROVIDED TO THE BOARD MEMBERS FOR REVIEW BEFORE FILING, EITHER AT A BOARD MEETING OR VIA E-MAIL. FORM 990, PART VI, SECTION B, LINE 12C AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE GOVERNING BOARD OR COMMITTEE MEETING, BUT AFTER THE PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. THE CHAIRPERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER THE CORPORATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE UNDER CIRCUMSTANCES NOT PRODUCING A CONFLICT OF INTEREST, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE CORPORATION'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION, IT SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.